Sugi Predict

Sugi Predict / Compounds / SCHEMBL23765260

SCHEMBL23765260

SCHEMBL23765260

CCCCCc1cc(OC(=O)c2ccc3ccccc3c2)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21

nearest known ligand 0.65

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 19/20 0.61
▸ CNR1 P21554 8/20 0.60
▸ ABHD12 Q8N2K0 3/20 0.60
▸ ABHD6 Q9BV23 3/20 0.60
▸ FAAH O00519 2/20 0.60
▸ NR1I2 O75469 1/20 0.60
▸ LDHA P00338 1/20 0.60
▸ GLRA1 P23415 1/20 0.60
▸ GPR183 P32249 1/20 0.60
▸ DRD3 P35462 1/20 0.60
▸ ENPP2 Q13822 1/20 0.60
▸ GPR18 Q14330 1/20 0.60
▸ TRPM8 Q7Z2W7 1/20 0.60
▸ GPR55 Q9Y2T6 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25268322 1.00 CNR2 (0.61) CNR2CNR1ABHD12ABHD6FAAH
SCHEMBL22946285 1.00 CNR2 (0.61) CNR2CNR1ABHD12ABHD6FAAH
SCHEMBL23765328 0.98 CNR2 (0.59) CNR2CNR1ABHD12ABHD6FAAH
SCHEMBL23765173 0.94 CNR2 (0.58) CNR2CNR1ABHD12ABHD6FAAH
SCHEMBL25258530 0.91 CNR2 (0.66) CNR2CNR1ABHD12ABHD6FAAH
SCHEMBL25258533 0.91 CNR2 (0.66) CNR2CNR1ABHD12ABHD6FAAH
SCHEMBL23765170 0.85 CNR1 (0.73) CNR2CNR1
SCHEMBL12715211 0.84 CNR2 (0.72) CNR2CNR1ABHD12ABHD6FAAH
SCHEMBL23249706 0.84 CNR2 (0.54) CNR2CNR1
SCHEMBL23249707 0.84 CNR2 (0.54) CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250059152-A1 CATALYTIC TETRAHYDROCANNABINOL SYNTHESIS AND PRECURSORS KARE CHEMICAL TECH INC (CA) 2025-02-20 — — US disclosed
US-20230381134-A1 COCRYSTALS OF CANNABINOIDS PURISYS LLC 2023-11-30 — — US disclosed
US-20230375561-A1 METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES KADDURAH DAOUK RIMA F (US) 2023-11-23 — — US disclosed
WO-2023102655-A1 CATALYTIC TETRAHYDROCANNABINOL SYNTHESIS AND PRECURSORS KARE CHEMICAL TECHNOLOGIES INC. (CA) 2023-06-15 — — WO disclosed
WO-2023102655-A1 CATALYTIC TETRAHYDROCANNABINOL SYNTHESIS AND PRECURSORS KARE CHEMICAL TECHNOLOGIES INC. (CA) 2023-06-15 — — WO disclosed
WO-2021163023-A1 STABLE FORMULATIONS OF DRONABINOL TRYAGx Labs Inc. (US) 2021-08-19 — — WO disclosed
US-20210251947-A1 STABLE FORMULATIONS OF DRONABINOL TRYAGx Labs Inc. 2021-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381134-A1 COCRYSTALS OF CANNABINOIDS CNR1, CNR2, GPR18 CNR2 2/4885CNR1 1/4885ABHD12 936/4885
US-20250059152-A1 CATALYTIC TETRAHYDROCANNABINOL SYNTHESIS AND PRECURSORS CNR2, CNR1, CES2 CNR2 1/4885CNR1 2/4885ABHD12 888/4885
US-20210251947-A1 STABLE FORMULATIONS OF DRONABINOL CNR2, CNR1, GPR18 CNR2 1/4885CNR1 2/4885ABHD12 1201/4885
US-20230375561-A1 METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES SLC25A20, CPT2, NDUFAB1 CNR2 91/4885CNR1 106/4885ABHD12 304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.